Tentative Approval — This application has been tentatively approved by the FDA but is not yet listed in the Orange Book. It is blocked from final approval by unexpired patents or exclusivities on the reference listed drug.
TOFACITINIB CITRATE
ANDATentative Approval
TOFACITINIB CITRATE | A220972 | SCIEGEN PHARMS
Products (2)
Sort:
#001 — EQ 11MG BASE
▴
TABLET, EXTENDED RELEASE;ORAL | Approved: N/A
No patent or exclusivity listings for this strength.